<DOC>
	<DOCNO>NCT03034018</DOCNO>
	<brief_summary>The aim study determine effect suvorexant insomnia symptom peri- postmenopausal woman experience sleep difficulty relate nighttime hot flash .</brief_summary>
	<brief_title>Efficacy Suvorexant Treatment Hot Flash-associated Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Peri postmenopausal woman DSM5 criterion Insomnia disorder , onset symptom attribute hot flash Some awakening cooccur hot flash Score Insomnia Severity Index ( ISI ) measure â‰¥15 Hot flash present , include night Diagnosis primary sleep disorder Shift worker Current expect use hypnotic medication Current major depressive episode Lifetime history bipolar disorder , psychosis , serious mental health problem Current alcohol/substance use disorder Obesity Renal hepatic disease Pregnancy breastfeed Recent malignancy Recent surgery Neurological disorder cardiovascular disease raise safety concern Medical instability consider interfere study procedure Concomitant medication drug interaction coadministration concern Contraindications allergic response suvorexant Recent plan travel across time zone Excessive coffee cigarette use</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>insomnia</keyword>
	<keyword>hot flash</keyword>
	<keyword>menopause</keyword>
	<keyword>suvorexant</keyword>
	<keyword>belsomra</keyword>
</DOC>